Today has been a truly remarkable day, with the majority of my key holdings ending blue and the combined portfolios soaring back into the black, with a buffer of £1,180.
I have had similar buffers wiped out in a day before, and the fact it only took a day to generate also points to the risk of it being ephemeral.
Today's price rises mean there has been a change in Nemesis Share. OPTI:Optibiotix has rewarded my faith and all the 64p top-ups by climbing to a bid price of 70p. Last week this was firmly ensconced as Nemesis Share with a £2,681 paper loss.
That was last Wednesday.
Today the loss is reduced to £635 and nowhere near Nemesis Share. With the value rising by £200 for every penny the share price rises, I suspect it may be contending for Star Share soon.
There are three shares performing worse than OPTI:Optibiotix.
LOOK:Lookers is losing £636 so is marginally worse, although you could argue that with £42 dividends this one is beating OPTI:Optibiotix, but showing absolutely no sign of recovering from the post-Brexit slump.
Basket case AFPO:African Potash is second to bottom of the pile, losing £714 and given it's close to going bust is unlikely to be in the portfolio much longer.
So the Nemesis Share title returns to KIBO:Kibo Mining, with paper losses of £814. I'm convinced these are under attack the same way as OPTI:Optibiotix are, but I'm anticipating a rise up to the launch of KAT:Katoro Mining on 23rd May in case that turns out to be the ex-date for free shares. This won't be Nemesis Share for long and climbed 5% today.
I have to mention Star Share, because IQE:IQE is absolutely staggering. It just won't stop going up! Today saw a 6.3% climb, taking the profit in my ISA to 137% and my SIPP to 48% and a total paper profit of £3,967. I can't believe that I nearly didn't buy them for my SIPP as I thought they had peaked. It was the global dominance in a field with high barriers to entry and soaring worldwide demand for its products that convinced me. Not unlike OPTI:Optibiotix! Every 1p rise in IQE:IQE is worth £121, and it's averaging more than that every day.
Last time I was this upbeat it all came crashing down around me. I really hope that doesn't happen this time...
Tuesday, 16 May 2017
Saturday, 13 May 2017
Week 92 Review - Partial recovery
A strong end to the week saw about half last week's losses recovered. Overall there was a £1,221.81 gain in portfolio value to £60,889.41 which is just £122.23 in the red.
There were no double-digit losers this week, and lots os small gains, however a big chunk of the recovery came from the double-digit risers. KIBO:Kibo Mining climbed 11% but is still making an overall loss. It did have a very positive impact on the paper losses though.
Share of the Week is IQE:IQE, which climbed 14% and every time I think it's run out of steam, the price carries on rising. The ISA holding is now 120% up on when I bought at 29.6p, with a bid price of 65.75p.
Hopefully nothing horrid will happen next week and we can get back in the black.
The ISA and share accounts look like this
The small drop in cost was due to making a small loss of £23.37 selling TW.:Taylor Wimpey, which was offset by the dividends. The proceeds were all re-invested in OPTI:Optibiotix which ended up by just 1p from last week, but the new shares were bought 1.5p cheaper than that price, so are already contributing towards reducing the Optibiotix losses. Portfolio value up by £1,019, of which about half was increased profit (mainly IQE:IQE) and half was reduced losses (mainly KIBO:Kibo Mining). No dividends so performance drops a little more than usual, and profits of 9.5% are 0.5% below my target, so I need to consider how best to rectify that.
Nice to see the green line going in the right direction again after a few torrid weeks.
The SIPP looks like this after week 76
The cost dropped because when I tried to re-invest the proceeds from selling some JLP:Jubilee Platinum in OPTI:Optibiotix I had to leave a limit order and was expecting to pay 66p but ended up paying 64.28p stranding some cash in my account. Overall a very quiet week, with an increase in value of just £110, but there's also the £69.26 profit taken. The effect on performance was negligible. Instead of the usual drops, performance improved by just 86p a month for year 2 and 76p a month overall.
Just need the two lines to start repelling each other and move apart.
The trading account looks like this after week 42
KIBO:Kibo Mining had a good week, so things are on the mend. So far this excercise is just proving the point that day trading is really hard, especially when you're not prepared to take a loss and end up stuck with shares for months. Having this sacrificial account is great though, as it allows me to focus my other accounts on long term investments without tempation to trade.
That's looking a little more promising now.
I was feeliong quite rebellious this week, mainly down to the strife with OPTI:Optibiotix appearing to be attacked, and I believe the same thing was happening to KIBO:Kibo Mining, although the main troll on their bulletin board was just a plain dickhead and I suspect too thick to be involved in shorting. He could have been taking cash from someone to spout gibberish on the bulletin board though. His attempts to post on half a dozen threads in order to hide the main thread seem to have failed miserbly, and it's pleasing that Kibo has recovered so well this week. With KAT:Katoro Mining listing from the reverse takeover of OPRA:Opera Investments on 23rd May, an announcement on share distribution to Kibo holders should see the price sneak a bit higher.
OPTI:Optibiotix had a great end to the week. If the shares were under attack, it's possible that is over, although a new troll has appeared on the bulletin board today, so it may be a while before things settle down. Each 1p recovery is now worth over £200, and the price needed to get back into profit is a few pence lower thanks to the 64p puchases this week. The best possible news next week would be the announcement of how SBTX:SkinBiotherapeutics shares are to be distributed amongst Optibiotix holders, and news on sales of LPLDL® following last week's launch and opportunity to do deals at the Vitafoods show alongside new partners Nutrilinea.
There were no double-digit losers this week, and lots os small gains, however a big chunk of the recovery came from the double-digit risers. KIBO:Kibo Mining climbed 11% but is still making an overall loss. It did have a very positive impact on the paper losses though.
Share of the Week is IQE:IQE, which climbed 14% and every time I think it's run out of steam, the price carries on rising. The ISA holding is now 120% up on when I bought at 29.6p, with a bid price of 65.75p.
Hopefully nothing horrid will happen next week and we can get back in the black.
The ISA and share accounts look like this
| Weekly Change | |||
| Portfolio cost | £42,556.91 | -£19.74 | |
| Portfolio sell value (bid price - commission) | £40,970.22 | (-3.7%) | +£1,019.32 |
| Potential profits | £4,052.42 | +£547.17 | |
| Yr 2 Dividends | £365.04 | +£0 | |
| Yr 2 Profit from sales | £2,401.06 | -£23.37 | |
| Yr 2 Average monthly cash profit | £296.00 | -£10.61 | |
| Yr 2 Avg annual % of current portfolio cost | 8.3% | ||
| Total Dividends | £1,032.97 | +£0 | |
| Total Profit from sales | £6.241.32 | -£23.37 | |
| Average monthly cash profit | £338.20 | -£5.01 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 9.5% |
The small drop in cost was due to making a small loss of £23.37 selling TW.:Taylor Wimpey, which was offset by the dividends. The proceeds were all re-invested in OPTI:Optibiotix which ended up by just 1p from last week, but the new shares were bought 1.5p cheaper than that price, so are already contributing towards reducing the Optibiotix losses. Portfolio value up by £1,019, of which about half was increased profit (mainly IQE:IQE) and half was reduced losses (mainly KIBO:Kibo Mining). No dividends so performance drops a little more than usual, and profits of 9.5% are 0.5% below my target, so I need to consider how best to rectify that.
Nice to see the green line going in the right direction again after a few torrid weeks.
The SIPP looks like this after week 76
| Weekly Change | |||
| Portfolio cost | £17,468.71 | -£28.15 | |
| Portfolio sell value (bid price - commission) | £19,041.57 | (+9.0%) | +£110.27 |
| Potential profits | £2,634.36 | +£8.03 | |
| Yr 2 Dividends | £0 | +£0 | |
| Yr 2 Profit from sales | £1,596.81 | +£69.26 | |
| Yr 2 Average monthly cash profit | £280.57 | +£0.86 | |
| Yr 2 Avg annual % of current portfolio cost | 19.3% | ||
| Total Dividends | £413.19 | +£0 | |
| Total Profit from sales | £3,946.67 | +£69.26 | |
| Average monthly cash profit | £243.25 | +£0.76 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 16.7% |
The cost dropped because when I tried to re-invest the proceeds from selling some JLP:Jubilee Platinum in OPTI:Optibiotix I had to leave a limit order and was expecting to pay 66p but ended up paying 64.28p stranding some cash in my account. Overall a very quiet week, with an increase in value of just £110, but there's also the £69.26 profit taken. The effect on performance was negligible. Instead of the usual drops, performance improved by just 86p a month for year 2 and 76p a month overall.
Just need the two lines to start repelling each other and move apart.
The trading account looks like this after week 42
| Weekly Change | |||
| Portfolio cost | £986.03 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £877.62 | (-11.0%) | +£72.48 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£2.36 | +£0.06 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | -2.9% |
KIBO:Kibo Mining had a good week, so things are on the mend. So far this excercise is just proving the point that day trading is really hard, especially when you're not prepared to take a loss and end up stuck with shares for months. Having this sacrificial account is great though, as it allows me to focus my other accounts on long term investments without tempation to trade.
That's looking a little more promising now.
I was feeliong quite rebellious this week, mainly down to the strife with OPTI:Optibiotix appearing to be attacked, and I believe the same thing was happening to KIBO:Kibo Mining, although the main troll on their bulletin board was just a plain dickhead and I suspect too thick to be involved in shorting. He could have been taking cash from someone to spout gibberish on the bulletin board though. His attempts to post on half a dozen threads in order to hide the main thread seem to have failed miserbly, and it's pleasing that Kibo has recovered so well this week. With KAT:Katoro Mining listing from the reverse takeover of OPRA:Opera Investments on 23rd May, an announcement on share distribution to Kibo holders should see the price sneak a bit higher.
OPTI:Optibiotix had a great end to the week. If the shares were under attack, it's possible that is over, although a new troll has appeared on the bulletin board today, so it may be a while before things settle down. Each 1p recovery is now worth over £200, and the price needed to get back into profit is a few pence lower thanks to the 64p puchases this week. The best possible news next week would be the announcement of how SBTX:SkinBiotherapeutics shares are to be distributed amongst Optibiotix holders, and news on sales of LPLDL® following last week's launch and opportunity to do deals at the Vitafoods show alongside new partners Nutrilinea.
Wednesday, 10 May 2017
Piled in to Optibiotix while it's cheap
I was enraged last night as I saw the OPTI:Optibiotix closing share price. On the day of a massive announcement that Nutrilinea will distribute LPLDL the new cardiovascular & cholesterol strain, the price plummeted!
I was dumbfounded - how can this constant barrage of good news result in the price going down relentlessly?
I began to smell a rat. A combination of factors. Over the last 3 weeks 470,000 shares have been "sold" in blocks of 10,000, and each time it seems to be dragging down the share price. Why would someone offloading choose to do that? Surely they would let the price rise, sell a batch and give it a chance to go up again before selling the next lot. To my (untrained) eyes this looks more like a concerted attack on the share.
OPTI:Optibiotix has 78.54 million shares in circulation. That's not a lot really. It's also relatively lightly traded, so a constant trickle of sizable blocks of shares coming onto the market will have an impact.
It's not a dead cert though - even taking out all the 10,000 blocks, there have been more sells than buys over the last three weeks, or at least trades reported as sells rather than buys, which are often incorrect.
As an aside, that's bloody ridiculous. Why are sites reporting buys and sells not able to state with certainty if it's a buy or sell? There's no reason to hide the reality, unless you want to manipulate people's perception of what's going on? The greatest gift that could be given to private investors would be a reform of this arcane practice and some real data to base our investment decisions on. It's madness that we're risking thousands of pounds on decisions informed by guesswork of what might have been bought or sold in a day. There you go ShareProphets - if you want to pick a fight with the establishment in order to help private investors, that's one that would be truly revolutionary!
Meanwhile, back on topic, and my supposition that there's share price manipulation going on here. I love reading bulletin boards. They are fun, and as long as you're careful with what you believe, they are informative too. The OPTI:Optibiotix bulletin board has some superb informed posters.
A while back on the GVC:GVC Holdings bulletin board, a load of trolls appeared claiming that GVC were about to be prosecuted. There was a constant barrage of negativity furiously denied by the regular posters. Over a four month period the share price dropped from around 750p to 600p. I wasn't overly concerned, having bought all mine at 422p, but it did hammer my paper profits. There was no reason for the decline, and exasperation was rife on the bulletin board from long term holders. Throughout this the trolls continued their drip drip drip of negativity.
Then it stopped. The trolls went away, and the share price has gone from 600p to 766p in 3.5 months.
So what was that all about?
If that wasn't a concerted shorting attack I don't know what it was.
Trolls have now invaded the OPTI:Optibiotix bulletin board. Exactly the same symptoms - a constant drip drip drip of negativity fueled by wild speculation and untruths.
Things like "placing imminent" when there's funding for 3 years even with no revenue.
Saying "No revenue for 3 years" when there's already revenue from Go Figure products that are about to go into another 200 stores, and when supply has already been made of LPLDL to generate revenue, and it only launched yesterday.
Things like "All the big boys will blow you out of the water" when the IP is absolutely watertight. It's a combination of bacteria species for goodness sake - how can you replicate that without using the same species? It's rather an easy infringement to prove.
I have managed to convince myself that OPTI:Optibiotix is under attack, and that makes me very angry. When someone's trying to screw you, you fight back. The only way I know to fight back is to take advantage of the shares being so cheap and buy more. Then when the attack stops, I'll be sure to have the last laugh - and my laugh will go on for decades!
First I had to find something I was willing to sell. That's easier said than done at the moment. I looked to my SIPP. Altogether I had over 150,000 shares in JLP:Jubilee Platinum, which has heaps of promise, but has tried my patience lately. Every time there seems to be a breakthrough or ground breaking news, the BoD manage to do something daft and the price gets clobbered again. I still think this will be a great share, but less great than OPTI:Optibiotix, so I sold the 55,306 in my SIPP for 4.4p after paying 4.22 and made a spectacular £69.26 (2.9%) profit. Frustrating given that it was making about £800 profit a few weeks ago! This liberated £2,421.51 for me to invest in OPTI:Optibiotix.
I bought 3,597 shares at 64.28p costing £2,324.10. I wanted more, but frustratingly they were not available to buy from an online quote this morning so I had to leave a limit order. Good news was my limit order was 66p which I thought was a bargain, and the price dropped even further so I got them cheaper, but have a small amount of cash stranded in my SIPP now until I sell something else. This purchase took my average price in the SIPP from 71.83p to 69.18p, so a return to the low 70's will put them in profit. For now they are losing £911 as the bid price has dropped to 61p - bugger!
As soon as the email came through confirming the limit order had been dealt and I saw the price, I grabbed my mobile phone and executed Plan B. After the misery of Brexit, TW.:Taylor Wimpey had finally climbed back to the 200p I bought them for, and when dividends are included were up by £42.09, with another dividend on the way soon, even if I sell now. I regretted buying housebuilder shares almost as soon as I got them. They pay great dividends but they are so volatile with the slightest change in sentiment of the housing market or interest rates or tax laws. Absolute nightmare, and I've wanted out but wouldn't take a loss. I sold my 600 shares today for 201.33p which without dividends was a £23.37 loss, basically the commission and amounts to 1.5%. This liberated £1,196.03 in my ISA. I could now get an online quote, so bought 1,848 OPTI:Optibiotix at 64.27p costing £1,199.66. This took my average ISA price from 78.7p to 76.15p. Given I bought a lot of these at 90p, this is a great result. The ISA holding is now losing £1,649.40 - Grr!
So, OPTI:Optibiotix now makes up 27.1% of my combined portfolios with 22,737 shares making a total paper loss of £2,681.78. What was that about a max 10% rule?
Ahahahahahahahahahaha!!!!!!!! What have I done?!
My shares in OPTI spin-off SBTX:SkinBiotherapeutics are down by 34% and losing £353,28 so between them they are down by three grand.
Ahahahahahahahahahaha!!!!!!!!
I just don't care - well - actually I do care quite a lot. I feel an anger and frustration deep deep down that the world can't see the promise about to explode from this company. Maybe it can see, but chooses to watch like a predator for the right moment to pounce. Kinda wish I'd done that now, but regret will evaporate if I get a bucket load of free SBTX:SkinBiotherapeutics shares for being invested here for so long.
That's it - Monday gave a great buffer, with combined portfolios up £800 from last week's catastrophe, but £500 of that vanished yesterday and another £700 today, so we're £388 in the red for the week and £1,732 in the red overall. I would have been feeling depressed and miserable after this week's price drops, but instead I feel elated and brimming with confidence that the worm will soon turn, and when it does it will be like one of them from Tremors and scoff everything in its path!
I was dumbfounded - how can this constant barrage of good news result in the price going down relentlessly?
I began to smell a rat. A combination of factors. Over the last 3 weeks 470,000 shares have been "sold" in blocks of 10,000, and each time it seems to be dragging down the share price. Why would someone offloading choose to do that? Surely they would let the price rise, sell a batch and give it a chance to go up again before selling the next lot. To my (untrained) eyes this looks more like a concerted attack on the share.
OPTI:Optibiotix has 78.54 million shares in circulation. That's not a lot really. It's also relatively lightly traded, so a constant trickle of sizable blocks of shares coming onto the market will have an impact.
It's not a dead cert though - even taking out all the 10,000 blocks, there have been more sells than buys over the last three weeks, or at least trades reported as sells rather than buys, which are often incorrect.
As an aside, that's bloody ridiculous. Why are sites reporting buys and sells not able to state with certainty if it's a buy or sell? There's no reason to hide the reality, unless you want to manipulate people's perception of what's going on? The greatest gift that could be given to private investors would be a reform of this arcane practice and some real data to base our investment decisions on. It's madness that we're risking thousands of pounds on decisions informed by guesswork of what might have been bought or sold in a day. There you go ShareProphets - if you want to pick a fight with the establishment in order to help private investors, that's one that would be truly revolutionary!
Meanwhile, back on topic, and my supposition that there's share price manipulation going on here. I love reading bulletin boards. They are fun, and as long as you're careful with what you believe, they are informative too. The OPTI:Optibiotix bulletin board has some superb informed posters.
A while back on the GVC:GVC Holdings bulletin board, a load of trolls appeared claiming that GVC were about to be prosecuted. There was a constant barrage of negativity furiously denied by the regular posters. Over a four month period the share price dropped from around 750p to 600p. I wasn't overly concerned, having bought all mine at 422p, but it did hammer my paper profits. There was no reason for the decline, and exasperation was rife on the bulletin board from long term holders. Throughout this the trolls continued their drip drip drip of negativity.
Then it stopped. The trolls went away, and the share price has gone from 600p to 766p in 3.5 months.
So what was that all about?
If that wasn't a concerted shorting attack I don't know what it was.
Trolls have now invaded the OPTI:Optibiotix bulletin board. Exactly the same symptoms - a constant drip drip drip of negativity fueled by wild speculation and untruths.
Things like "placing imminent" when there's funding for 3 years even with no revenue.
Saying "No revenue for 3 years" when there's already revenue from Go Figure products that are about to go into another 200 stores, and when supply has already been made of LPLDL to generate revenue, and it only launched yesterday.
Things like "All the big boys will blow you out of the water" when the IP is absolutely watertight. It's a combination of bacteria species for goodness sake - how can you replicate that without using the same species? It's rather an easy infringement to prove.
I have managed to convince myself that OPTI:Optibiotix is under attack, and that makes me very angry. When someone's trying to screw you, you fight back. The only way I know to fight back is to take advantage of the shares being so cheap and buy more. Then when the attack stops, I'll be sure to have the last laugh - and my laugh will go on for decades!
First I had to find something I was willing to sell. That's easier said than done at the moment. I looked to my SIPP. Altogether I had over 150,000 shares in JLP:Jubilee Platinum, which has heaps of promise, but has tried my patience lately. Every time there seems to be a breakthrough or ground breaking news, the BoD manage to do something daft and the price gets clobbered again. I still think this will be a great share, but less great than OPTI:Optibiotix, so I sold the 55,306 in my SIPP for 4.4p after paying 4.22 and made a spectacular £69.26 (2.9%) profit. Frustrating given that it was making about £800 profit a few weeks ago! This liberated £2,421.51 for me to invest in OPTI:Optibiotix.
I bought 3,597 shares at 64.28p costing £2,324.10. I wanted more, but frustratingly they were not available to buy from an online quote this morning so I had to leave a limit order. Good news was my limit order was 66p which I thought was a bargain, and the price dropped even further so I got them cheaper, but have a small amount of cash stranded in my SIPP now until I sell something else. This purchase took my average price in the SIPP from 71.83p to 69.18p, so a return to the low 70's will put them in profit. For now they are losing £911 as the bid price has dropped to 61p - bugger!
As soon as the email came through confirming the limit order had been dealt and I saw the price, I grabbed my mobile phone and executed Plan B. After the misery of Brexit, TW.:Taylor Wimpey had finally climbed back to the 200p I bought them for, and when dividends are included were up by £42.09, with another dividend on the way soon, even if I sell now. I regretted buying housebuilder shares almost as soon as I got them. They pay great dividends but they are so volatile with the slightest change in sentiment of the housing market or interest rates or tax laws. Absolute nightmare, and I've wanted out but wouldn't take a loss. I sold my 600 shares today for 201.33p which without dividends was a £23.37 loss, basically the commission and amounts to 1.5%. This liberated £1,196.03 in my ISA. I could now get an online quote, so bought 1,848 OPTI:Optibiotix at 64.27p costing £1,199.66. This took my average ISA price from 78.7p to 76.15p. Given I bought a lot of these at 90p, this is a great result. The ISA holding is now losing £1,649.40 - Grr!
So, OPTI:Optibiotix now makes up 27.1% of my combined portfolios with 22,737 shares making a total paper loss of £2,681.78. What was that about a max 10% rule?
Ahahahahahahahahahaha!!!!!!!! What have I done?!
My shares in OPTI spin-off SBTX:SkinBiotherapeutics are down by 34% and losing £353,28 so between them they are down by three grand.
Ahahahahahahahahahaha!!!!!!!!
I just don't care - well - actually I do care quite a lot. I feel an anger and frustration deep deep down that the world can't see the promise about to explode from this company. Maybe it can see, but chooses to watch like a predator for the right moment to pounce. Kinda wish I'd done that now, but regret will evaporate if I get a bucket load of free SBTX:SkinBiotherapeutics shares for being invested here for so long.
That's it - Monday gave a great buffer, with combined portfolios up £800 from last week's catastrophe, but £500 of that vanished yesterday and another £700 today, so we're £388 in the red for the week and £1,732 in the red overall. I would have been feeling depressed and miserable after this week's price drops, but instead I feel elated and brimming with confidence that the worm will soon turn, and when it does it will be like one of them from Tremors and scoff everything in its path!
Friday, 5 May 2017
Week 91 Review - Horrid
This has been an utterly catastrophic week, with one of the biggest declines in portfolio value since I started investing. The combined portfolios crashed in value by £2,986.55 leaving them £1,344.04 in the red. This wasn't helped by cashing in about £700 profit, but that's still well over £2,000 down.
Just a fleeting dalliance above the red line. It looked so bright a few weeks ago, but now despair has set in.
Amazingly there was only one double-digit loser amongst the declines, with JLP:Jubilee Platinum declining 10%, but in my SIPP the effect of bedding my share account holdings into my existing ISA holding meant the value dropped by 26% compared with the cost. There were 5% and 6% drops in a large number of shares to drag down the overall performance
The share and ISA accounts look like this
Portfolio cost went up when the JLP:Jubilee Platinum shares from my trading account got moved into my ISA. Massive drop in value, over half of which was loss of potential profit which is very painful. £34.87 was the profit I made from selling JLP:Jubilee Platinum as part of the bedding.
That's a steeper fall than when Trump got elected!
The SIPP looks like this after week 75
The sale of CWR:Ceres Power did great things for my performance, but savaged the paper profits. Even without the sale they would have fallen £400 which is a lot for this portfolio.
The lines are irresistibly attracted to each other!
The trading account looks like this after week 41
My desire to bed JLP:Jubilee Platinum into my ISA as a long term holding meant I was willing to savage my profits and cut the capital invested back to the £1,000 that was meant to be used to seed this account. I need something amazing to happen to KIBO:Kibo Mining or REDS:RedstoneConnect in the next 11 weeks or my first annual trading report will be embarrassing!
Yeah whatever...
I'm not going to write anything about how excited I am for what's going to happen next week. OPTI:Optibiotix launch the new cholesterol product, so hopefully the current share price madness will reverse, and maybe they will announce how we're getting free SBTX:SkinBiotherapeutics shares.
KIBO:Kibo Mining announced the reverse takeover of OPRA:Opera Investments today, so KAT:Katoro Mining will start trading on 23rd May. Will we get free shares out of the 61 million Kibo will be allocated?
I don't want another week like this one thank you very much.
Just a fleeting dalliance above the red line. It looked so bright a few weeks ago, but now despair has set in.
Amazingly there was only one double-digit loser amongst the declines, with JLP:Jubilee Platinum declining 10%, but in my SIPP the effect of bedding my share account holdings into my existing ISA holding meant the value dropped by 26% compared with the cost. There were 5% and 6% drops in a large number of shares to drag down the overall performance
The share and ISA accounts look like this
| Weekly Change | |||
| Portfolio cost | £42,576.65 | +£446.39 | |
| Portfolio sell value (bid price - commission) | £39,950.90 | (-6.2%) | -£1,645.20 |
| Potential profits | £3,505.25 | -£944.76 | |
| Yr 2 Dividends | £365.04 | +£0 | |
| Yr 2 Profit from sales | £2,424.43 | +£34.87 | |
| Yr 2 Average monthly cash profit | £306.61 | -£4.09 | |
| Yr 2 Avg annual % of current portfolio cost | 8.6% | ||
| Total Dividends | £1,032.97 | +£7.94 | |
| Total Profit from sales | £6.264.69 | +£34.87 | |
| Average monthly cash profit | £343.21 | -£2.13 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 9.7% |
Portfolio cost went up when the JLP:Jubilee Platinum shares from my trading account got moved into my ISA. Massive drop in value, over half of which was loss of potential profit which is very painful. £34.87 was the profit I made from selling JLP:Jubilee Platinum as part of the bedding.
The SIPP looks like this after week 75
| Weekly Change | |||
| Portfolio cost | £17,496.86 | +£720.17 | |
| Portfolio sell value (bid price - commission) | £18,959.45 | (+8.4%) | -£1,354.89 |
| Potential profits | £2,626.33 | -£1,108.21 | |
| Yr 2 Dividends | £0 | +£0 | |
| Yr 2 Profit from sales | £1,527.55 | +£685.48 | |
| Yr 2 Average monthly cash profit | £279.71 | +£120.87 | |
| Yr 2 Avg annual % of current portfolio cost | 19.2% | ||
| Total Dividends | £413.19 | +£0 | |
| Total Profit from sales | £3,877.41 | +£685.48 | |
| Average monthly cash profit | £242.49 | +£36.44 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 16.6% |
The sale of CWR:Ceres Power did great things for my performance, but savaged the paper profits. Even without the sale they would have fallen £400 which is a lot for this portfolio.
The lines are irresistibly attracted to each other!
The trading account looks like this after week 41
| Weekly Change | |||
| Portfolio cost | £986.03 | -£495.95 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £805.14 | (-18.3%) | -£482.42 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | -£22.85 | -£84.42 | |
| Average monthly cash profit | -£2.42 | -£9.09 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | -2.9% |
My desire to bed JLP:Jubilee Platinum into my ISA as a long term holding meant I was willing to savage my profits and cut the capital invested back to the £1,000 that was meant to be used to seed this account. I need something amazing to happen to KIBO:Kibo Mining or REDS:RedstoneConnect in the next 11 weeks or my first annual trading report will be embarrassing!
Yeah whatever...
I'm not going to write anything about how excited I am for what's going to happen next week. OPTI:Optibiotix launch the new cholesterol product, so hopefully the current share price madness will reverse, and maybe they will announce how we're getting free SBTX:SkinBiotherapeutics shares.
KIBO:Kibo Mining announced the reverse takeover of OPRA:Opera Investments today, so KAT:Katoro Mining will start trading on 23rd May. Will we get free shares out of the 61 million Kibo will be allocated?
I don't want another week like this one thank you very much.
Thursday, 4 May 2017
Bargain basement Optibiotix
I couldn't watch OPTI:Optibiotix selling at 67p the week before launching its revolutionary cholesterol product without buying some.
I turned to my SIPP, where CWR:Ceres Power has done really well for me, buying at 5.52p I sold this morning at 8.41p making £685.48 (48.5%) profit. I still hold 21,099 shares in my ISA so I'm not abandoning them, but I feel there is a lot of potential competition in the fuel cell market, so a little de-risking and taking some profit would be wise.
This liberated over £2,000 so I was able to buy 3,145 OPTI:Optibiotix shares at a staggeringly cheap 67p costing £2,119.10 with commission.
My OPTI:Optibiotix position is now way, way over what I set as my maximum to invest in one company, with 21.3% of my portfolio invested in this share. It's also my Nemesis Share, losing £1,664.67 but it's my favourite share, just because the potential is so utterly staggering that I can't envisage a scenario where it doesn't become huge.
The products are backed by scientific research and real-life trials, there is IP that nobody has found a way to break, there are massive multi-national companies queuing up to partner, there are free shares in SBTX:SkinBiotherapeutics about to be dished out, a huge cholesterol-reducing ingredient is about to be released to the masses next week, SweetBiotix is gearing up for launch at the end of the year and could end up in every fizzy drink, Slimbiome is selling well despite no advertising and at some point is likely to be taken up by SlimFast, and Steve O'Hara the CEO has a proven track record of creating successful companies, and has recruited a top-notch team to commercialise the products.
Yet the share price has plummeted to 67p - what on earth is going on?
Let's see what happens next week...
I turned to my SIPP, where CWR:Ceres Power has done really well for me, buying at 5.52p I sold this morning at 8.41p making £685.48 (48.5%) profit. I still hold 21,099 shares in my ISA so I'm not abandoning them, but I feel there is a lot of potential competition in the fuel cell market, so a little de-risking and taking some profit would be wise.
This liberated over £2,000 so I was able to buy 3,145 OPTI:Optibiotix shares at a staggeringly cheap 67p costing £2,119.10 with commission.
My OPTI:Optibiotix position is now way, way over what I set as my maximum to invest in one company, with 21.3% of my portfolio invested in this share. It's also my Nemesis Share, losing £1,664.67 but it's my favourite share, just because the potential is so utterly staggering that I can't envisage a scenario where it doesn't become huge.
The products are backed by scientific research and real-life trials, there is IP that nobody has found a way to break, there are massive multi-national companies queuing up to partner, there are free shares in SBTX:SkinBiotherapeutics about to be dished out, a huge cholesterol-reducing ingredient is about to be released to the masses next week, SweetBiotix is gearing up for launch at the end of the year and could end up in every fizzy drink, Slimbiome is selling well despite no advertising and at some point is likely to be taken up by SlimFast, and Steve O'Hara the CEO has a proven track record of creating successful companies, and has recruited a top-notch team to commercialise the products.
Yet the share price has plummeted to 67p - what on earth is going on?
Let's see what happens next week...
Wednesday, 3 May 2017
Carnage - but Jubilee safe in the ISA
What the hell's going on?
Today was utter carnage, with the whole portfolio bar two shares red and ironically those two are RDT:Rosslyn Data and TRK:Torotrak which are both delinquent basket cases!
The combined portfolios lost £1,100 today, and yesterday was almost as bad so we're £1,782 down this week and £139 in the red overall. The buffer has been annihilated.
Never mind, at least my JLP:Jubilee Platinum shares got bedded into my ISA today.
I cocked up a little, as I also bedded the shares that count towards my trading account. It all got a bit messy trying to disentangle them, and I don't really want to have any trading shares in the ISA, so I wrote them off my trading account as a loss and will keep them in my ISA. Unfortunately it means the £500 won't now get liberated to go towards the Visa bill, but I think I'd rather keep the shares anyway.
So the impact of all this is that I made a whopping £34.87 (0.6%) from the sale in my share account seeing as the price has plummeted. I'd hoped bedding these would get me back over my 10% target but it hasn't happened.
I sold a total of 90,207 at 4.5125p and bought back 89,545 at 4.5325p. so I lost 662 shares worth £29.87 which is ok for the protection from tax.
The effect on the trading account was horrid. That resulted in a £84.42 loss and means my performance on that account is now -£22.85. I find myself laughing hysterically at what an utter disaster my attempt at short-term trading has been. So glad I'm doing it with a tiny percentage of the portfolio.
Today has made me very miserable. OPTI:Optibiotix dropped another 2p and is losing £1,571. KIBO:Kibo Mining dropped 0.25p and is losing £1,169.53 which means OPTI:Optibiotix re-gains the title of Nemesis Share. It also means I may just buy some more tomorrow as 67.5p is an absolute steal given the new cardio products are being launched next week. Tomorrow morning could be very interesting....
Today was utter carnage, with the whole portfolio bar two shares red and ironically those two are RDT:Rosslyn Data and TRK:Torotrak which are both delinquent basket cases!
The combined portfolios lost £1,100 today, and yesterday was almost as bad so we're £1,782 down this week and £139 in the red overall. The buffer has been annihilated.
Never mind, at least my JLP:Jubilee Platinum shares got bedded into my ISA today.
I cocked up a little, as I also bedded the shares that count towards my trading account. It all got a bit messy trying to disentangle them, and I don't really want to have any trading shares in the ISA, so I wrote them off my trading account as a loss and will keep them in my ISA. Unfortunately it means the £500 won't now get liberated to go towards the Visa bill, but I think I'd rather keep the shares anyway.
So the impact of all this is that I made a whopping £34.87 (0.6%) from the sale in my share account seeing as the price has plummeted. I'd hoped bedding these would get me back over my 10% target but it hasn't happened.
I sold a total of 90,207 at 4.5125p and bought back 89,545 at 4.5325p. so I lost 662 shares worth £29.87 which is ok for the protection from tax.
The effect on the trading account was horrid. That resulted in a £84.42 loss and means my performance on that account is now -£22.85. I find myself laughing hysterically at what an utter disaster my attempt at short-term trading has been. So glad I'm doing it with a tiny percentage of the portfolio.
Today has made me very miserable. OPTI:Optibiotix dropped another 2p and is losing £1,571. KIBO:Kibo Mining dropped 0.25p and is losing £1,169.53 which means OPTI:Optibiotix re-gains the title of Nemesis Share. It also means I may just buy some more tomorrow as 67.5p is an absolute steal given the new cardio products are being launched next week. Tomorrow morning could be very interesting....
Tuesday, 2 May 2017
Week 90 Review
A rather traumatic week saw the combined portfolios end up with a difference between cost and value that was £351.29 better than last week. However, the cost reduced by £833.76 due to the £1,167 loss from the AFG:Aquatic Foods sale minus the £242.63 profit from bedding some AMYT:Amryt Pharma shares into my ISA and £100 I added from my current account. So in reality, the portfolio suffered a paper loss of £482.
Worst performer was RDT:Rosslyn Data which dropped 14% after announcing a placing at a significant discount to the current price. They also announced an open offer, which I have decided to accept, as I get 294 shares for just £13.23 with no commission. This will drop my average purchase price from 17.52p to 15.85p for hardly any money. I really don't know if this share will ever recover, but I'm happy to take a risk for such a small amount to increase the value of any recovery.
My other double-digit loser was KIBO:Kibo Mining which continues to disappoint, dropping 11% and taking the paper loss to £1,169.53.That demotes it to Nemesis Share as OPTI:Optiobiotix is losing a mere £1,147.06. Both of these were making big profits not long ago - when both were in a much less optimistic position than they are now. It really doesn't make sense!
The Share of the Week is the only double-digit riser this week, and it's my old favourite Star Share IQE:IQE, climbing 15% and now standing at £2,937.96 potential profit.I think there's a lot further for this one to go, although wouldn't be surprised if there's a pull back at some point - and I'll be ready to buy more if it does!
Still in overall profit, but the buffer has been obliterated.
The ISA and share portfolios look like this
The most complex weekly update ever! I've changed the way the formula works for defining sell value, as it usually takes off any increase in portfolio cost. With the portfolio cost dropping by £833 this week, it showed a rise in sell value which was plain wrong. Now, if the cost has gone down, then that figure isn't taken off the sell value difference. So there's been a drop of £516.15 this week, with most being deepening losses, as potential profits are up £59. There was a quarterly dividend from CMCL:Caledonia Mining of £7.94. Nice to have that regular income, I really should buy more! Profit from sales was hammered by the AFG:Aquatic Food disaster which drags this year's performance down by over £100 a month, and overall performance down by £48 a month. Pretty depressing, but at least I saved £900 from almost certain doom if I hadn't sold my shares.
Doesn't so much fly as plummet...
Here's the SIPP after week 74
Not bad. Potential profits up nicely by £234, but drops in OPTI:Optibiotix and JLP:Jubilee Platinum ate most of that up. Average monthly performance still way over target 10%, which is good as there's nothing I really want to sell in this portfolio - except WRES:W Resources which was a big mistake.
Still happy with this one
The trading account looks like this after week 40
Although an unmitigated disaster based on my expectations, a return of 5.4% isn't bad, if I ever recover the 13.1 paper loss on the portfolio, which I'm sure I will one day...
Urrrrg...
So this week I offloaded one of my two big howlers, with AFG:Aquatic Food biting the dust. My other big howler AFPO:African Potash is currently suspended and I'm not intending to sell as the transaction would cost me £6.38 with the returns not even covering the commission. At some point they will go bust, and my performance will be hit by another big loss, this time of £714. When it happens, I will certainly need to sell something for a similar profit else I risk sinking well below my 10% target for the ISA/shares accounts.
I don't think anything interesting will happen next week. It's a short week with bank holiday, no results or trading statements expected, and I'm quite relieved as there was too much excitement this week. I've decided to leave my bed & ISA order open for JLP:Jubilee Platinum, just to see how long it takes for Hargreaves Lansdown to actually do anything about it. I'm hoping I can rely on them to be sensible and make the transfer when there's a small spread and no volatility, else I'll be somewhat peeved. At current prices that will generate £296 profit from the sale, so should get my average performance back over the magic 10%.
Worst performer was RDT:Rosslyn Data which dropped 14% after announcing a placing at a significant discount to the current price. They also announced an open offer, which I have decided to accept, as I get 294 shares for just £13.23 with no commission. This will drop my average purchase price from 17.52p to 15.85p for hardly any money. I really don't know if this share will ever recover, but I'm happy to take a risk for such a small amount to increase the value of any recovery.
My other double-digit loser was KIBO:Kibo Mining which continues to disappoint, dropping 11% and taking the paper loss to £1,169.53.That demotes it to Nemesis Share as OPTI:Optiobiotix is losing a mere £1,147.06. Both of these were making big profits not long ago - when both were in a much less optimistic position than they are now. It really doesn't make sense!
The Share of the Week is the only double-digit riser this week, and it's my old favourite Star Share IQE:IQE, climbing 15% and now standing at £2,937.96 potential profit.I think there's a lot further for this one to go, although wouldn't be surprised if there's a pull back at some point - and I'll be ready to buy more if it does!
Still in overall profit, but the buffer has been obliterated.
The ISA and share portfolios look like this
| Weekly Change | |||
| Portfolio cost | £42,130.26 | -£833.76 | |
| Portfolio sell value (bid price - commission) | £41,149.71 | (-2.3%) | -£516.15 |
| Potential profits | £4,450.01 | +£59.98 | |
| Yr 2 Dividends | £365.04 | +£7.94 | |
| Yr 2 Profit from sales | £2,389.56 | -£925.23 | |
| Yr 2 Average monthly cash profit | £310.70 | -£115.83 | |
| Yr 2 Avg annual % of current portfolio cost | 8.8% | ||
| Total Dividends | £1,032.97 | +£7.94 | |
| Total Profit from sales | £6.229.82 | -£925.23 | |
| Average monthly cash profit | £345.34 | -£48.54 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 9.8% |
The most complex weekly update ever! I've changed the way the formula works for defining sell value, as it usually takes off any increase in portfolio cost. With the portfolio cost dropping by £833 this week, it showed a rise in sell value which was plain wrong. Now, if the cost has gone down, then that figure isn't taken off the sell value difference. So there's been a drop of £516.15 this week, with most being deepening losses, as potential profits are up £59. There was a quarterly dividend from CMCL:Caledonia Mining of £7.94. Nice to have that regular income, I really should buy more! Profit from sales was hammered by the AFG:Aquatic Food disaster which drags this year's performance down by over £100 a month, and overall performance down by £48 a month. Pretty depressing, but at least I saved £900 from almost certain doom if I hadn't sold my shares.
Doesn't so much fly as plummet...
Here's the SIPP after week 74
| Weekly Change | |||
| Portfolio cost | £16,776.69 | +£0 | |
| Portfolio sell value (bid price - commission) | £19,594.17 | (+16.8%) | +£87.39 |
| Potential profits | £3,734.54 | +£234.74 | |
| Yr 2 Dividends | £0 | +£0 | |
| Yr 2 Profit from sales | £842.07 | +£0 | |
| Yr 2 Average monthly cash profit | £158.84 | -£7.57 | |
| Yr 2 Avg annual % of current portfolio cost | 11.4% | ||
| Total Dividends | £413.19 | +£0 | |
| Total Profit from sales | £3,191.93 | +£0 | |
| Average monthly cash profit | £206.05 | -£2.83 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 14.7% |
Not bad. Potential profits up nicely by £234, but drops in OPTI:Optibiotix and JLP:Jubilee Platinum ate most of that up. Average monthly performance still way over target 10%, which is good as there's nothing I really want to sell in this portfolio - except WRES:W Resources which was a big mistake.
The trading account looks like this after week 40
| Weekly Change | |||
| Portfolio cost | £1,481.98 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,287.56 | (-13.1%) | -£53.71 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | £61.57 | +£0 | |
| Average monthly cash profit | £6.67 | -£0.17 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 5.4% |
Although an unmitigated disaster based on my expectations, a return of 5.4% isn't bad, if I ever recover the 13.1 paper loss on the portfolio, which I'm sure I will one day...
Urrrrg...
So this week I offloaded one of my two big howlers, with AFG:Aquatic Food biting the dust. My other big howler AFPO:African Potash is currently suspended and I'm not intending to sell as the transaction would cost me £6.38 with the returns not even covering the commission. At some point they will go bust, and my performance will be hit by another big loss, this time of £714. When it happens, I will certainly need to sell something for a similar profit else I risk sinking well below my 10% target for the ISA/shares accounts.
I don't think anything interesting will happen next week. It's a short week with bank holiday, no results or trading statements expected, and I'm quite relieved as there was too much excitement this week. I've decided to leave my bed & ISA order open for JLP:Jubilee Platinum, just to see how long it takes for Hargreaves Lansdown to actually do anything about it. I'm hoping I can rely on them to be sensible and make the transfer when there's a small spread and no volatility, else I'll be somewhat peeved. At current prices that will generate £296 profit from the sale, so should get my average performance back over the magic 10%.
Subscribe to:
Posts (Atom)